STOCK TITAN

Sharps Technology, Inc. - $STSS STOCK NEWS

Welcome to our dedicated page for Sharps Technology news (Ticker: $STSS), a resource for investors and traders seeking the latest updates and insights on Sharps Technology stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sharps Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sharps Technology's position in the market.

Rhea-AI Summary
Sharps Technology, Inc. announces definitive agreement for purchase and sale of shares and warrants in registered direct offering, expected to generate approximately $5.6 million in gross proceeds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.4%
Tags
none
-
Rhea-AI Summary
Sharps Technology announces $50 million acquisition of InjectEZ, strengthening manufacturing capacity and establishing leading position in copolymer prefillable syringe system industry. Nephron commits to minimum orders of over $400 million over 10 years, generating $30 million in revenue the first year and subsequent minimum orders totaling over $45 million in annual revenue through December 2033. Acquisition enables entry into highly profitable syringe segment with high growth potential. Sharps Technology well positioned for future growth and meaningful benefits to patients and shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.19%
Tags
-
Rhea-AI Summary
Sharps Technology, Inc. announces the appointment of Ben Scheu as Senior Director of Sales to lead commercial operations as the Company prepares to launch its specialty smart safety syringe products to the market. Mr. Scheu has a proven track record of driving revenue growth and will focus on launching the Securegard® disposable smart safety syringe product line and the next-generation polymer-based prefilled syringe systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.75%
Tags
management
Rhea-AI Summary
Sharps Technology, Inc. announces advancements in commercialization of Securegard smart safety syringe product line through qualification programs with a major medical device company. Production of prefilled syringe products will begin in Q4 2023 to support co-manufacturing agreement with Nephron Pharmaceuticals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.97%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.16%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.27%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.27%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.16%
Tags
none
Sharps Technology, Inc.

Nasdaq:STSS

STSS Rankings

STSS Stock Data

7.49M
12.09M
7.88%
16.8%
1.47%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MELVILLE